Endovastec(SH:688016) Shang Hai Zheng Quan Bao·2025-04-21 21:05Core Viewpoint - The company, Shanghai MicroPort MedBot (Group) Co., Ltd., will participate in the 2024 annual performance briefing for the medical device industry organized by the Shanghai Stock Exchange, aiming to provide investors with insights into its 2024 operational results and financial status [2][3]. Group 1: Event Details - The investor briefing will be held on April 25, 2025, from 15:00 to 17:00, in an online interactive format via the Shanghai Stock Exchange Roadshow Center [6][7]. - Investors can submit questions in advance until April 24, 2025, at 16:00, either through the Roadshow Center or via the company's email [5][6]. Group 2: Participants - Key participants in the briefing include Dr. Zhu Qing (CEO), Mr. Ye Xiaojie (Independent Director), Mr. Liu Hao (Vice President of Treatment Solutions), Mr. Qiu Genyong (Vice President and Board Secretary), and Ms. Li Chunfang (Senior Financial Director) [4]. Group 3: Contact Information - For inquiries, investors can contact the Board Office at 021-38139300 or via email at irm@endovastec.com [8].